{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:59:50Z","timestamp":1753891190974,"version":"3.41.2"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T00:00:00Z","timestamp":1634256000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Interstitial lung diseases (ILDs) are often associated with rheumatic diseases. Their early diagnosis and management are not only difficult, but also crucial, because they are associated with major morbidity and mortality and can be the first cause of death in autoimmune rheumatic diseases (ARDs).<\/jats:p><jats:p><jats:bold>Objectives:<\/jats:bold> By using methodologies, such as Nominal Group Technique (NGT) and Delphi Survey, the aims of this study were (1) to measure consensus between pulmonologists, radiologists, and rheumatologists experienced in the management of ARD-ILD; (2) to highlight the importance of a multidisciplinary approach; and (3) to provide clinicians with a practical tool aimed at improving the prompt recognition and follow-up of ILD associated with ARDs and of any possible rheumatic conditions underlying ILD.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> During the NGT round, the Steering Committee defined 57 statements to be used in the Delphi survey. A total of 78 experts participated in the Delphi survey, namely 28 pulmonologists, 33 rheumatologists, and 17 radiologists. During this round, consensus on agreement was reached in 47 statements, while disagreement was not reached in any statements. A secondary questionnaire was drafted by the Steering Committee to obtain clearer indications on ILD-ARD \u201cred-flags\u201d and follow-up. Delphi Panelists took part also in the second-questionnaire survey. Answers from both surveys were used to draft two checklists of \u201cred flags\u201d sign or symptom suggestive of ILD and ARD, respectively, and two checklists on identification and monitoring of rheumatoid arthritis (RA) and systemic sclerosis (SSc) ILD.<\/jats:p><jats:p><jats:bold>Limitations:<\/jats:bold> This study is a consensus work, which cannot produce empiric data, and is limited to the Italian scenario.<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold> This work showed a high level of agreement, but also shows some divergent opinions between different experts. This underlines the importance of a multidisciplinary approach. Eventually, we believe the drafted checklists can help clinicians in the diagnosis and follow-up of ILD-ARD.<\/jats:p>","DOI":"10.3389\/fmed.2021.732761","type":"journal-article","created":{"date-parts":[[2021,10,16]],"date-time":"2021-10-16T00:43:28Z","timestamp":1634345008000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Interstitial Lung Disease Associated With Autoimmune Rheumatic Diseases: Checklists for Clinical Practice"],"prefix":"10.3389","volume":"8","author":[{"given":"Silvia Laura","family":"Bosello","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Beretta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicoletta","family":"Del Papa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Harari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Palmucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Pesci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilda","family":"Rechichi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Varone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Sebastiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,10,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.autrev.2015.09.003","article-title":"Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: our interdisciplinary rheumatology-pneumology experience, and review of the literature","volume":"15","author":"Ferri","year":"2016","journal-title":"Autoimmun Rev."},{"key":"B2","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3390\/diagnostics10040208","article-title":"Patients with interstitial lung disease secondary to autoimmune diseases: how to recognize them?","volume":"10","author":"Sambataro","year":"2020","journal-title":"Diagnostics."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.3899\/jrheum.171314","article-title":"Rheumatological assessment is important for interstitial lung disease diagnosis","volume":"45","author":"Levi","year":"2018","journal-title":"J Rheumatol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3389\/fmed.2019.00246","article-title":"The role of the multidisciplinary evaluation of interstitial lung diseases: systematic literature review of the current evidence and future perspectives","volume":"6","author":"Furini","year":"2019","journal-title":"Front Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1183\/13993003.00150-2015","article-title":"An official European Respiratory Society\/American Thoracic Society research statement: interstitial pneumonia with autoimmune features","volume":"46","author":"Fischer","year":"2015","journal-title":"Eur Respir J."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1513\/AnnalsATS.202003-214PS","article-title":"Progressive fibrosing interstitial lung disease. a proposed integrated algorithm for management","volume":"17","author":"Varone","year":"2020","journal-title":"Ann Am Thorac Soc."},{"key":"B7","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s00296-016-3636-7","article-title":"Interstitial lung disease in systemic sclerosis: current and future treatment","volume":"37","author":"Giacomelli","year":"2017","journal-title":"Rheumatol Int."},{"key":"B8","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.rdc.2015.04.006","article-title":"Management of systemic-sclerosis-associated interstitial lung disease","volume":"41","author":"Silver","year":"2015","journal-title":"Rheum Dis Clin North Am."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1007\/s10067-013-2289-0","article-title":"Mortality in systemic sclerosis-a single centre study from the UK","volume":"32","author":"Strickland","year":"2013","journal-title":"Clin Rheumatol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1164\/rccm.201004-0622OC","article-title":"Rheumatoid arthritis-interstitial lung disease-associated mortality","volume":"183","author":"Olson","year":"2011","journal-title":"Am J Respir Crit Care Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1183\/16000617.0011-2021","article-title":"Interstitial lung disease in rheumatoid arthritis","volume":"12","author":"Ascherman","year":"2010","journal-title":"Curr Rheumatol Rep."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1183\/09031936.00092309","article-title":"Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease","volume":"35","author":"Kim","year":"2010","journal-title":"Eur Respir J."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1016\/S2665-9913(19)30144-4","article-title":"The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements","volume":"2","author":"Hoffmann-Vold","year":"2020","journal-title":"Lancet Rheumatol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/biomedicines9010017","article-title":"Interstitial pneumonia with autoimmune features: why rheumatologist-pulmonologist collaboration is essential","volume":"9","author":"Sebastiani","year":"2020","journal-title":"Biomedicines."},{"key":"B15","doi-asserted-by":"publisher","first-page":"664","DOI":"10.3390\/diagnostics10090664","article-title":"Multidisciplinary evaluation of interstitial lung diseases: new opportunities linked to rheumatologist involvement","volume":"10","author":"De Lorenzis","year":"2020","journal-title":"Diagnostics (Basel)."},{"key":"B16","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1136\/bmj.311.7001.376","article-title":"Consensus methods for medical and health services research","volume":"311","author":"Jones","year":"1995","journal-title":"BMJ."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1056\/nejm197306142882405","article-title":"Medical assessment by a delphi group opinion technic","volume":"288","author":"Milholland","year":"1973","journal-title":"N Engl J Med."},{"volume-title":"Come Organizzare Una Conferenza di Consenso. Manuale Metodologico Sistema Nazionale per le Linee Guida","year":"2019","author":"Candiani","key":"B18"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1007\/s10067-019-04720-0","article-title":"Progressive fibrosing interstitial lung disease associated with systemic autoimmune diseases","volume":"38","author":"Fischer","year":"2019","journal-title":"Clin Rheumatol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1136\/annrheumdis-2017-211138","article-title":"population-based cohort study of rheumatoid arthritis-associated interstitial lung disease: comorbidity and mortality","volume":"76","author":"Hyldgaard","year":"2017","journal-title":"Ann Rheum Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"360","DOI":"10.3899\/jrheum.171315","article-title":"Rheumatoid arthritis-interstitial lung disease in the united states: prevalence, incidence, and healthcare costs and mortality","volume":"46","author":"Raimundo","year":"2019","journal-title":"J Rheumatol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1002\/art.27405","article-title":"Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study","volume":"62","author":"Bongartz","year":"2010","journal-title":"Arthritis Rheum."},{"key":"B23","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1164\/ajrccm.156.2.9609016","article-title":"Interstitial lung disease in recent onset rheumatoid arthritis","volume":"156","author":"Gabbay","year":"1997","journal-title":"Am J Respir Crit Care Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1136\/thorax.56.8.622","article-title":"Fibrosing alveolitis in patients with rheumatoid arthritis as assessed by high resolution computed tomography, chest radiography, and pulmonary function tests","volume":"56","author":"Dawson","year":"2001","journal-title":"Thorax."},{"key":"B25","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1001\/archinternmed.2007.59","article-title":"Progressive preclinical interstitial lung disease in rheumatoid arthritis","volume":"168","author":"Gochuico","year":"2008","journal-title":"Arch Intern Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1093\/rheumatology\/keu165","article-title":"Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics\u2013a large multicentre UK study","volume":"53","author":"Kelly","year":"2014","journal-title":"Rheumatology (Oxford)."},{"key":"B27","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s10067-017-3561-5","article-title":"Retrospective study of the clinical characteristics and risk factors of rheumatoid arthritis-associated interstitial lung disease","volume":"36","author":"Zhang","year":"2017","journal-title":"Clin Rheumatol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1007\/s10067-018-04421-0","article-title":"Elevated anti-cyclic citrullinated peptide antibody titer is associated with increased risk for interstitial lung disease","volume":"38","author":"Correia","year":"2019","journal-title":"Clin Rheumatol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1164\/rccm.201411-1950OC","article-title":"Detection of rheumatoid arthritis-interstitial lung disease is enhanced by serum biomarkers","volume":"191","author":"Doyle","year":"2015","journal-title":"Am J Respir Crit Care Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1164\/rccm.2106012","article-title":"Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome","volume":"165","author":"Bouros","year":"2002","journal-title":"Am J Respir Crit Care Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1164\/rccm.200607-912OC","article-title":"Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes","volume":"175","author":"Park","year":"2007","journal-title":"Am J Respir Crit Care Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s00296-017-3893-0","article-title":"Interstitial lung disease in South Africans with systemic sclerosis","volume":"38","author":"Ashmore","year":"2018","journal-title":"Rheumatol Int."},{"key":"B34","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1136\/ard.62.2.97","article-title":"Predictors of end stage lung disease in systemic sclerosis","volume":"62","author":"Steen","year":"2003","journal-title":"Ann Rheum Dis."},{"key":"B35","doi-asserted-by":"publisher","first-page":"588","DOI":"10.3109\/14397595.2015.1115455","article-title":"Incidence and predictors of interstitial lung disease (ILD) in Thai patients with early systemic sclerosis: inception cohort study","volume":"26","author":"Wangkaew","year":"2016","journal-title":"Mod Rheumatol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1902026","DOI":"10.1183\/13993003.02026-2019","article-title":"Predictors of progression in systemic sclerosis patients with interstitial lung disease","volume":"55","author":"Distler","year":"2020","journal-title":"Eur Respir J."},{"key":"B37","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12931-019-0980-7","article-title":"Interstitial lung disease associated with systemic sclerosis (SSc-ILD)","volume":"20","author":"Cottin","year":"2019","journal-title":"Respir Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1136\/annrheumdis-2018-213708","article-title":"Short-term progression of interstitial lung disease in systemic sclerosis predicts long-term survival in two independent clinical trial cohorts","volume":"78","author":"Volkmann","year":"2019","journal-title":"Ann Rheum Dis."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1002\/art.40130","article-title":"Short-term pulmonary function trends are predictive of mortality in interstitial lung disease associated with systemic sclerosis","volume":"69","author":"Goh","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1590\/s1806-37132011000100015","article-title":"Myositis-related interstitial lung disease and antisynthetase syndrome","volume":"37","author":"Solomon","year":"2011","journal-title":"J Bras Pneumol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","article-title":"Diagnosis of idiopathic pulmonary fibrosis. An official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"198","author":"Raghu","year":"2018","journal-title":"Am J Respir Crit Care Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"00209","DOI":"10.1183\/23120541.00209-2018","article-title":"The characterisation of interstitial lung disease multidisciplinary team meetings: a global study","volume":"5","author":"Richeldi","year":"2019","journal-title":"ERJ Open Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"6452","DOI":"10.1038\/s41598-019-42813-7","article-title":"The role of follow-up evaluation in the diagnostic algorithm of idiopathic interstitial pneumonia: a retrospective study","volume":"9","author":"Han","year":"2019","journal-title":"Sci Rep."},{"key":"B44","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","article-title":"An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management","volume":"183","author":"Raghu","year":"2011","journal-title":"Am J Respir Crit Care Med."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.732761\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,16]],"date-time":"2021-10-16T00:43:31Z","timestamp":1634345011000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.732761\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,15]]},"references-count":44,"alternative-id":["10.3389\/fmed.2021.732761"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2021.732761","relation":{},"ISSN":["2296-858X"],"issn-type":[{"type":"electronic","value":"2296-858X"}],"subject":[],"published":{"date-parts":[[2021,10,15]]},"article-number":"732761"}}